Gilead Sciences GILD Total costs & expenses

Total costs & expenses at other companies

Bristol-Myers SquibbBMY

$8.89B-15.3%

IncyteINCY

$976.14M+42.5%

ImmunityBio, Inc.IBRX

$114M+40.8%

Iovance Biotherapeutics, Inc.IOVA

$151.22M-13.0%

Vir Biotechnology, Inc.VIR

$165.48M+38.3%

CG OncologyCGON

$87.56M+79.6%

FAQ

What is Gilead Sciences's total costs & expenses?

Gilead Sciences (GILD) reported total costs & expenses of $18.2B in Q2 2026.

How has Gilead Sciences's total costs & expenses changed year-over-year?

Gilead Sciences's total costs & expenses increased by 294.9% year-over-year, from $4.61B to $18.2B.

What is the long-term trend for Gilead Sciences's total costs & expenses?

Over 4 years (2021 to 2025), Gilead Sciences's total costs & expenses has grown at a 2.8% compound annual growth rate (CAGR), from $17.39B to $19.42B.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue during a specific reporting period. It encompasses cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to assess the company's overall cost structure and operational efficiency in supporting its core business activities.